Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion

Reuters10-29

Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion

Ekso Bionics Holdings Inc. has released a presentation outlining its recent activities and advancements in wearable robotic technology for health and daily life. The company highlighted its focus on neuro-rehabilitation, with FDA-approved devices for the treatment of traumatic brain injury, stroke, spinal cord injury, and multiple sclerosis. Ekso Bionics reported over 1,000 devices deployed in more than 500 centers globally and noted the integration of its technology in inpatient and outpatient rehabilitation settings, as well as VA medical centers. The presentation detailed case studies showing increased patient volume and reduced length of stay at facilities utilizing EksoNR, in addition to improved productivity for therapists. Financing options and third-party partnerships for device acquisition were also discussed. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ekso Bionics Holdings Inc. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579994193?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-29 04:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579994193","market":"nz","top_or_hot":-1,"title":"Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/EKSO\">Ekso Bionics Holdings Inc</a>. has released a presentation outlining its recent activities and advancements in wearable robotic technology for health and daily life. The company highlighted its focus on neuro-rehabilitation, with FDA-approved devices for the treatment of traumatic brain injury, stroke, spinal cord injury, and multiple sclerosis. Ekso Bionics reported over 1,000 devices deployed in more than 500 centers globally and noted the integration of its technology in inpatient and outpatient rehabilitation settings, as well as VA medical centers. The presentation detailed case studies showing increased patient volume and reduced length of stay at facilities utilizing EksoNR, in addition to improved productivity for therapists. Financing options and third-party partnerships for device acquisition were also discussed. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ekso Bionics Holdings Inc. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEkso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-29 04:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/EKSO\">Ekso Bionics Holdings Inc</a>. has released a presentation outlining its recent activities and advancements in wearable robotic technology for health and daily life. The company highlighted its focus on neuro-rehabilitation, with FDA-approved devices for the treatment of traumatic brain injury, stroke, spinal cord injury, and multiple sclerosis. Ekso Bionics reported over 1,000 devices deployed in more than 500 centers globally and noted the integration of its technology in inpatient and outpatient rehabilitation settings, as well as VA medical centers. The presentation detailed case studies showing increased patient volume and reduced length of stay at facilities utilizing EksoNR, in addition to improved productivity for therapists. Financing options and third-party partnerships for device acquisition were also discussed. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ekso Bionics Holdings Inc. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EKSO","symbol_name":"Ekso Bionics Holdings Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDLJzMVW:1","article_id":"2579994193","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579994193","pubTimestamp":1761683071,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Ekso Bionics Holdings Inc. has released a presentation outlining its recent activities and advancements in wearable robotic technology for health and daily life. The company highlighted its focus on neuro-rehabilitation, with FDA-approved devices for the treatment of traumatic brain injury, stroke, spinal cord injury, and multiple sclerosis. Ekso Bionics reported over 1,000 devices deployed in more than 500 centers globally and noted the integration of its technology in inpatient and outpatient rehabilitation settings, as well as VA medical centers. The presentation detailed case studies showing increased patient volume and reduced length of stay at facilities utilizing EksoNR, in addition to improved productivity for therapists. Financing options and third-party partnerships for device acquisition were also discussed. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Whi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EKSO":"Ekso Bionics Holdings Inc","BK4082":"医疗保健设备"},"translate_title":"Ekso Bionics推出投资者演示文稿，重点介绍机器人康复和市场扩张","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EKSO":0.9},"content_text":"Ekso Bionics Unveils Investor Presentation Highlighting Robotic Rehabilitation and Market Expansion\n    \n\nEkso Bionics Holdings Inc. has released a presentation outlining its recent activities and advancements in wearable robotic technology for health and daily life. The company highlighted its focus on neuro-rehabilitation, with FDA-approved devices for the treatment of traumatic brain injury, stroke, spinal cord injury, and multiple sclerosis. Ekso Bionics reported over 1,000 devices deployed in more than 500 centers globally and noted the integration of its technology in inpatient and outpatient rehabilitation settings, as well as VA medical centers. The presentation detailed case studies showing increased patient volume and reduced length of stay at facilities utilizing EksoNR, in addition to improved productivity for therapists. Financing options and third-party partnerships for device acquisition were also discussed. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ekso Bionics Holdings Inc. published the original content used to generate this news brief on October 28, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579994193","isCrawlerRequest":true}